H1N1 Vaccination Campaign Will Build Active Surveillance System To Monitor Guillian-Barres Syndrome
This article was originally published in The Pink Sheet Daily
Multi-faceted effort includes text messages to vaccinees, a grant for Johns Hopkins, and extra funding for 10 state health departments.
You may also be interested in...
An FDA panel said the H1N1 flu vaccine should be given in two doses when the probable vaccine campaign starts in the fall, but government officials at the meeting said there will not likely be enough vaccine available at that point to follow that advice
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
With an unrestricted label and once-daily dosing, rivaroxaban will do battle with Boehringer-Ingelheim's dabigatran, which is dosed twice a day but can claim superior efficacy to warfarin in the atrial fibrillation population.